Clonal Hematopoiesis and Its Impact on Cardiovascular Disease.
暂无分享,去创建一个
[1] M. J. Peebles. Relationship , 2020, Definitions.
[2] John G Doench,et al. PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells. , 2018, Blood.
[3] M. Dubé,et al. Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A. , 2018, Blood.
[4] K. Ballman,et al. Somatic mutations precede acute myeloid leukemia years before diagnosis , 2018, Nature Medicine.
[5] Paolo Vineis,et al. Prediction of acute myeloid leukaemia risk in healthy individuals , 2018, Nature.
[6] O. Abdel-Wahab,et al. Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation , 2018, The Journal of experimental medicine.
[7] Tom Lenaerts,et al. Evolutionary dynamics of paroxysmal nocturnal hemoglobinuria , 2018, PLoS Comput. Biol..
[8] R. Handsaker,et al. Insights about clonal hematopoiesis from 8,342 mosaic chromosomal alterations , 2018, Nature.
[9] K. Walsh,et al. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease , 2018, Circulation research.
[10] S. Mccarroll,et al. Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms , 2018, Science Translational Medicine.
[11] Markus G. Manz,et al. Molecular Minimal Residual Disease in Acute Myeloid Leukemia , 2018, The New England journal of medicine.
[12] P. Libby,et al. Roles of PAD4 and NETosis in Experimental Atherosclerosis and Arterial Injury: Implications for Superficial Erosion , 2018, Circulation research.
[13] D. Goukassian,et al. Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome. , 2018, Journal of the American College of Cardiology.
[14] K. Walsh,et al. Somatic Mutations and Clonal Hematopoiesis: Unexpected Potential New Drivers of Age-Related Cardiovascular Disease , 2018, Circulation research.
[15] R. Levine,et al. Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies. , 2018, Cell stem cell.
[16] Christopher A. Miller,et al. Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential , 2018, Nature Communications.
[17] B. Göttgens,et al. From haematopoietic stem cells to complex differentiation landscapes , 2018, Nature.
[18] Peter J. Park,et al. Aging and neurodegeneration are associated with increased mutations in single human neurons , 2017, Science.
[19] P. Libby,et al. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial , 2017, The Lancet.
[20] Y. Hayashi,et al. Expansion of EPOR-negative macrophages besides erythroblasts by elevated EPOR signaling in erythrocytosis mouse models , 2017, Haematologica.
[21] Raquel S. Sevilla,et al. Exome-wide association study of plasma lipids in >300,000 individuals , 2017, Nature Genetics.
[22] Scott W. Lowe,et al. Putting p53 in Context , 2017, Cell.
[23] M. Ladanyi,et al. Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes. , 2017, Cell stem cell.
[24] Christopher A. Miller,et al. Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignancies. , 2017, The Journal of clinical investigation.
[25] P. Libby,et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.
[26] Kari Stefansson,et al. Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. , 2017, Blood.
[27] T. Hsiao,et al. The distinct biological implications of Asxl1 mutation and its roles in leukemogenesis revealed by a knock-in mouse model , 2017, Journal of Hematology & Oncology.
[28] M. Nahrendorf,et al. Flow Perturbation Mediates Neutrophil Recruitment and Potentiates Endothelial Injury via TLR2 in Mice: Implications for Superficial Erosion , 2017, Circulation research.
[29] S. Gabriel,et al. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease , 2017, The New England journal of medicine.
[30] A. Mead,et al. Myeloproliferative neoplasm stem cells. , 2017, Blood.
[31] Matthew A. Cooper,et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice , 2017, Science.
[32] C. Balestrieri,et al. Dnmt3a restrains mast cell inflammatory responses , 2017, Proceedings of the National Academy of Sciences.
[33] B. Schraven,et al. JAK2-V617F activates β1-integrin-mediated adhesion of granulocytes to vascular cell adhesion molecule 1 , 2017, Leukemia.
[34] A. LaCasce,et al. Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] M. Teixeira,et al. Truncating and missense PPM1D mutations in early‐onset and/or familial/hereditary prostate cancer patients , 2016, Genes, chromosomes & cancer.
[36] B. Ebert,et al. The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia , 2016, Nature Reviews Cancer.
[37] O. Abdel-Wahab,et al. The Role of Additional Sex Combs-Like Proteins in Cancer. , 2016, Cold Spring Harbor perspectives in medicine.
[38] Nicholas Eriksson,et al. Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms. , 2016, Blood.
[39] T. Druley,et al. Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults , 2016, Nature Communications.
[40] M. Rivas,et al. Mosaic mutations in blood DNA sequence are associated with solid tumor cancers , 2016, bioRxiv.
[41] Wei Li,et al. DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells , 2016, Nature Genetics.
[42] Xia Li,et al. Methyltransferase Dnmt3a upregulates HDAC9 to deacetylate the kinase TBK1 for activation of antiviral innate immunity , 2016, Nature Immunology.
[43] K. Nakayama,et al. Truncation mutants of ASXL1 observed in myeloid malignancies are expressed at detectable protein levels. , 2016, Experimental hematology.
[44] T. Walsh,et al. Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian Carcinoma. , 2016, JAMA oncology.
[45] T. Rando,et al. Stem cells and healthy aging , 2015, Science.
[46] Xia Li,et al. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6 , 2015, Nature.
[47] D. Belsky,et al. Quantification of biological aging in young adults , 2015, Proceedings of the National Academy of Sciences.
[48] M. Hebrok,et al. DNA methylation directs functional maturation of pancreatic β cells. , 2015, The Journal of clinical investigation.
[49] H. Lähdesmäki,et al. Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1–BAP1 complex , 2015, Nature Communications.
[50] V. Fuster,et al. Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study , 2015, Circulation.
[51] P. Libby,et al. TLR2 and neutrophils potentiate endothelial stress, apoptosis and detachment: implications for superficial erosion. , 2015, European heart journal.
[52] M. Stratton,et al. High burden and pervasive positive selection of somatic mutations in normal human skin , 2015, Science.
[53] D. Butkiewicz,et al. Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients , 2015, British Journal of Cancer.
[54] E. Zeggini,et al. Leukemia-Associated Somatic Mutations Drive Distinct Patterns of Age-Related Clonal Hemopoiesis , 2015, Cell reports.
[55] M. Kessel,et al. Endothelial p53 Deletion Improves Angiogenesis and Prevents Cardiac Fibrosis and Heart Failure Induced by Pressure Overload in Mice , 2015, Journal of the American Heart Association.
[56] M. McCarthy,et al. Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.
[57] Christopher A. Miller,et al. The Role of TP53 Mutations in the Origin and Evolution of Therapy-Related AML , 2014, Nature.
[58] S. Gabriel,et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.
[59] Joshua F. McMichael,et al. Age-related cancer mutations associated with clonal hematopoietic expansion , 2014, Nature Medicine.
[60] Aviv Regev,et al. Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing , 2014, Nature Biotechnology.
[61] Jan Vijg,et al. Somatic mutations, genome mosaicism, cancer and aging. , 2014, Current opinion in genetics & development.
[62] Zhaomin Li,et al. Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice. , 2014, Blood.
[63] C. Mason,et al. Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo , 2013, The Journal of experimental medicine.
[64] C Haferlach,et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes , 2013, Leukemia.
[65] H. Aburatani,et al. Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutations. , 2013, The Journal of clinical investigation.
[66] P. Bushel,et al. p53 integrates host defense and cell fate during bacterial pneumonia , 2013, The Journal of experimental medicine.
[67] Matthew D. Schultz,et al. Epigenomic Analysis of Multilineage Differentiation of Human Embryonic Stem Cells , 2013, Cell.
[68] S. Bojesen,et al. Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population , 2013, British journal of haematology.
[69] Peter Donnelly,et al. Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer , 2012, Nature.
[70] T. Sauka-Spengler,et al. DNA methyltransferase3A as a molecular switch mediating the neural tube-to-neural crest fate transition. , 2012, Genes & development.
[71] Zhigang Xue,et al. Dnmt3a regulates both proliferation and differentiation of mouse neural stem cells , 2012, Journal of neuroscience research.
[72] Mithat Gonen,et al. Recurrent Somatic TET2 Mutations in Normal Elderly Individuals With Clonal Hematopoiesis , 2012, Nature Genetics.
[73] Iannis Aifantis,et al. ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression. , 2012, Cancer cell.
[74] E. Moding,et al. p53 Functions in Endothelial Cells to Prevent Radiation-Induced Myocardial Injury in Mice , 2012, Science Signaling.
[75] Joshua F. McMichael,et al. The Origin and Evolution of Mutations in Acute Myeloid Leukemia , 2012, Cell.
[76] William Wheeler,et al. Detectable clonal mosaicism and its relationship to aging and cancer , 2012, Nature Genetics.
[77] H. Hasselbalch,et al. Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer? , 2012, Blood.
[78] M. Kaplan,et al. DNA methyltransferase 3a limits the expression of interleukin-13 in T helper 2 cells and allergic airway inflammation , 2011, Proceedings of the National Academy of Sciences.
[79] J. Berg,et al. Dnmt3a is essential for hematopoietic stem cell differentiation , 2011, Nature Genetics.
[80] Wenyong Zhang,et al. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. , 2011, Blood.
[81] Yang Wang,et al. Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA , 2011, Science.
[82] Chuan He,et al. Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine , 2011, Science.
[83] Allon M. Klein,et al. Universal patterns of stem cell fate in cycling adult tissues , 2011, Development.
[84] O. Abdel-Wahab,et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. , 2011, Cancer cell.
[85] P. Opolon,et al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. , 2011, Cancer cell.
[86] D. Neuberg,et al. Clinical effect of point mutations in myelodysplastic syndromes. , 2011, The New England journal of medicine.
[87] C. Schumann,et al. Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[88] S. Bojesen,et al. The JAK2 V617F somatic mutation, mortality and cancer risk in the general population , 2011, Haematologica.
[89] H. Kantarjian,et al. Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond , 2011, Nature Reviews Drug Discovery.
[90] I. Komuro,et al. Promotion of CHIP-Mediated p53 Degradation Protects the Heart From Ischemic Injury , 2010, Circulation research.
[91] R. Medzhitov,et al. p53-mediated hematopoietic stem and progenitor cell competition. , 2010, Cell stem cell.
[92] W. Nelson,et al. Identification of DNA Methyltransferase 3a as a T Cell Receptor-Induced Regulator of Th1 and Th2 Differentiation1 , 2009, The Journal of Immunology.
[93] David R. Liu,et al. Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1 , 2009, Science.
[94] E. Abraham,et al. p53 Attenuates Lipopolysaccharide-Induced NF-κB Activation and Acute Lung Injury 1 , 2009, The Journal of Immunology.
[95] L. Zon,et al. Hematopoiesis: An Evolving Paradigm for Stem Cell Biology , 2008, Cell.
[96] K. Sunagawa,et al. Targeted deletion of p53 prevents cardiac rupture after myocardial infarction in mice. , 2006, Cardiovascular research.
[97] Stefan N. Constantinescu,et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera , 2005, Nature.
[98] L. Chan,et al. Macrophage-Specific p53 Expression Plays a Crucial Role in Atherosclerosis Development and Plaque Remodeling , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[99] Eric J Topol,et al. Prevalence of conventional risk factors in patients with coronary heart disease. , 2003, JAMA.
[100] M. Fiscella,et al. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[101] D. Gilliland,et al. Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age. , 1996, Blood.